Drug recall · June 13, 2018
Nystatin Oral Suspension recall
Why: Resuspension problems: Out of specification for appearance and resuspendability.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Nystatin Oral Suspension, USP, 500,000 units/5 mL, For Institutional Use Only, packaged in 5 mL cups, Rx Only, Pharmaceutical Associates, Inc. Greenville, SC 29605, NDC 0121-4810-05
- Lots / codes
Lot: B5B8 Exp. 07/2019
- Quantity
- 275400 cups
- Company
- Pharmaceutical Associates Inc, Greenville, SC
- Distribution
- Nationwide
- Initiated
- May 29, 2018 · Voluntary: Firm initiated
- Classified
- June 13, 2018
- Reported
- June 13, 2018
- Ended
- January 13, 2020
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Nystatin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.